EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. [electronic resource]
Producer: 20090508Description: 436-40 p. digitalISSN:- 1399-3003
- Adenocarcinoma -- pathology
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Central Nervous System Neoplasms -- secondary
- Drug Resistance, Neoplasm
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Gefitinib
- Humans
- Liver Neoplasms -- secondary
- Lung Neoplasms -- pathology
- Male
- Neoplasm Metastasis
- Quinazolines -- administration & dosage
- Recurrence
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.